Screener
iRadimed IRMD Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by iRadimed in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The source filing: iRadimed’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Financing activities: | ||
| Dividends paid | (2,556) | (2,162) |
| Taxes paid related to the net share settlement of equity awards | (50) | (116) |
| Net cash used in financing activities | (2,606) | (2,278) |
| Net increase (decrease) in cash and cash equivalents | 5,215 | (1,903) |
| Cash and cash equivalents, beginning of period | 51,159 | 52,234 |
| Cash and cash equivalents, end of period | $56,374 | $50,331 |
| Supplemental disclosure of cash flow information: |
Item 1. Condensed Financial Statements
FAQ
- What is iRadimed's financing cash flow?
- iRadimed (IRMD) reported financing cash flow of -$2.61M in Q1 2026.
- How has iRadimed's financing cash flow changed year-over-year?
- iRadimed's financing cash flow decreased by 14.4% year-over-year, from -$2.28M to -$2.61M.
- What is the long-term trend for iRadimed's financing cash flow?
- Over 4 years (2021 to 2025), iRadimed's financing cash flow has grown at a 418.1% compound annual growth rate (CAGR), from $24.43K to -$17.6M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.
Ask your AI about iRadimed's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude